APPG calls for long term conditions to be part of new pharmacy contract

APPG calls for long term conditions to be part of new pharmacy contract

July 16 2018 Community pharmacy’s involvement in managing long term conditions should be...

NICE updates guideline on rheumatoid arthritis

NICE updates guideline on rheumatoid arthritis

July 13 2018 NICE has issued a new version of its guideline on the management of rheumatoid...

RPS seeks views on draft guidance around polypharmacy

RPS seeks views on draft guidance around polypharmacy

July 13 2018 The Royal Pharmaceutical Society is seeking comments to hone draft guidance on...

NMS sees 4.5% referral rate to GP for newly prescribed antihypertensives

NMS sees 4.5% referral rate to GP for newly prescribed antihypertensives

July 11 2018 New Medicines Service data indicates community pharmacists manage 19 out of 20...

PDA: ‘Pharmacy technicians don’t want to be responsible for supervising pharmacies’

PDA: ‘Pharmacy technicians don’t want to be responsible for supervising pharmacies’

July 10 2018 Pharmacy technicians have indicated concerns about the possibility that their role...

  • APPG calls for long term conditions to be part of new pharmacy contract

    APPG calls for long term conditions to be part of new pharmacy contract

    Monday, 16 July 2018 15:44
  • NICE updates guideline on rheumatoid arthritis

    NICE updates guideline on rheumatoid arthritis

    Friday, 13 July 2018 12:51
  • RPS seeks views on draft guidance around polypharmacy

    RPS seeks views on draft guidance around polypharmacy

    Friday, 13 July 2018 12:47
  • NMS sees 4.5% referral rate to GP for newly prescribed antihypertensives

    NMS sees 4.5% referral rate to GP for newly prescribed antihypertensives

    Wednesday, 11 July 2018 13:02
  • PDA: ‘Pharmacy technicians don’t want to be responsible for supervising pharmacies’

    PDA: ‘Pharmacy technicians don’t want to be responsible for supervising pharmacies’

    Tuesday, 10 July 2018 09:23

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

a blood pressure monitor imageJuly 11 2018

New Medicines Service data indicates community pharmacists manage 19 out of 20 hypertensive patients without the need to refer a patient back to the GP.

Analysis of 131,419 patient records in England has found that 4.5% of patients were referred by a pharmacist to a GP within the first two weeks of starting a new antihypertensive medication. The patients most commonly referred to the GP were those experiencing side effects, but other significant influences on referral were medication-related concerns and the drug class.

In terms of drug class, the introduction of an alpha blocker into the patient’s therapy was most likely to result in a referral, while patients prescribed angiotensin-II receptor blockers were least likely to be referred. 

The findings have been published in the British Journal of General Practice, with the researchers looking at data relating to the introduction of the New Medicines Service in 2011-12. It found that the mean age of patients assessed under the NMS was 65 years.

“These data are reassuring, in that additional pharmacist involvement does not increase medical workload appreciably, and support further development of pharmacist-led hypertension interventions,” said the researchers from the Nuffield Department of Primary Care Health Sciences, University of Oxford.

The researchers commented that pharmacists could manage patients’ negative feelings towards the new medication and uncertainty as to their efficacy. The concerns “could be managed via BP measurements, verbal advice, and reassurance, and do not require a pharmacist to have a prescribing qualification.” 

However, the significance of these negative feelings and uncertainties in the results “suggests that patients may not be accepting pharmacist advice and recommendations, or that pharmacists may not consistently offer this.”

Link:
A Albrasi et al. ‘Hypertension referrals from community pharmacy to general practice: multivariate logistic regression analysis of 131 419 patients’. Br J Gen Pract 5 July 2018; bjgp18X697925.        

Practice News

July 16 2018 Community pharmacy’s involvement in managing long term conditions should be better recognised by the Government, parliamentarians have said.
July 11 2018 New Medicines Service data indicates community pharmacists manage 19 out of 20 hypertensive patients without the need to refer a patient back to the GP. Analysis of 131,419 patient...